Updates are available Correction dated 2023-02-23

Article History

Accepted: 9 January 2023

First Online: 7 February 2023

Change Date: 23 February 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.3758/s13415-023-01078-4

Declarations

:

: HF has no financial or non-financial interests to declare. OJR's MRC senior fellowship is partially in collaboration with Cambridge Cognition Ltd (who plan to provide in-kind contribution) and he is running an investigator-initiated trial with medication donated by Lundbeck (escitalopram and placebo, no financial contribution). He also holds an MRC-Proximity to discovery award with Roche (who provide in-kind contributions and have sponsored travel for ACP) regarding work on heart-rate variability and anxiety. He also has completed consultancy work on affective bias modification for Peak and online CBT for IESO digital health. OJR sits on the committee of the British Association of Psychopharmacology. In the past 3 years, JPR has held a PhD studentship co-funded by Cambridge Cognition and performed consultancy work for GE Ltd. These disclosures are made in the interest of full transparency and do not constitute a conflict of interest with the current work.

: This study was approved by the UCL Research Ethics Committee, reference 6198/001, and the study was performed in accordance with the Declaration of Helsinki.

: All participants gave informed consent before taking part.

: All participants consented to publication of their anonymised data before taking part.